Literature DB >> 23537080

Emerging roles of NUCB2/nesfatin-1 in the metabolic control of reproduction.

David García-Galiano1, Manuel Tena-Sempere.   

Abstract

Nesfatin-1, derived from the precursor NEFA/nucleobindin2 (NUCB2), was initially identified as a feeding-suppressing neuropeptide, acting at central (mainly, hypothalamic) levels in a leptin-independent manner. However, recent experimental evidence strongly suggests that, rather than being a simple anorectic hypothalamic signal, nesfatin-1 operates at different tissues as an integral regulator of energy homeostasis and closely related neuroendocrine functions. On the latter, growing, albeit as yet fragmentary, evidence has pointed out recently that NUCB2/ nesfatin-1 is involved in the regulation of different aspects of reproductive maturation and function, by acting probably at different levels of the hypothalamic-pituitary-gonadal (HPG) axis. As documented by rodent studies, the reproductive facet of nesfatin-1 likely includes (i) a permissive role in (female) pubertal maturation, (ii) stimulatory effects on the gonadotropic axis, whose magnitude, in terms of LH responses, varies depending on the maturational stage and probably the sex and species, and (iii) direct expression and actions in the gonads. These features, together with the proven expression of NUCB2/nesfatin-1 in tissues with essential roles in the metabolic control of reproduction, such as the hypothalamus, adipose and pancreas, support a putative role of nesfatin-1 as neurohormonal signal linking body metabolic status, puberty and fertility. Curiously enough, although its reproductive dimension seems to be conserved in non-mammalian vertebrates, recent studies in goldfish have surfaced predominant inhibitory actions of nesfatin-1 at different levels of the HPG axis in fish. These findings illustrate our as yet limited understanding of this aspect of nesfatin-1 physiology, whose relevance in the joint control of metabolism and reproduction in health and disease warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537080     DOI: 10.2174/138161281939131127142531

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Immunohistochemical localization and possible functions of nesfatin-1 in the testis of mice during pubertal development and sexual maturation.

Authors:  Ashutosh Ranjan; Mayank Choubey; Toshihiko Yada; Amitabh Krishna
Journal:  J Mol Histol       Date:  2019-09-20       Impact factor: 2.611

2.  Leptin, ghrelin, nesfatin-1, and orexin-A plasma levels in girls with premature thelarche.

Authors:  N Almasi; H Y Zengin; N Koç; S A Uçakturk; D İskender Mazman; N Heidarzadeh Rad; M Fisunoglu
Journal:  J Endocrinol Invest       Date:  2022-06-28       Impact factor: 5.467

Review 3.  Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.

Authors:  Jagoda Kruszewska; Hanna Laudy-Wiaderny; Michał Kunicki
Journal:  Int J Environ Res Public Health       Date:  2022-02-13       Impact factor: 3.390

4.  Nesfatin-1 decreases excitability of dopaminergic neurons in the substantia nigra.

Authors:  Chen Li; Fang Zhang; Limin Shi; Haoyun Zhang; Zibin Tian; Junxia Xie; Hong Jiang
Journal:  J Mol Neurosci       Date:  2013-11-13       Impact factor: 3.444

5.  Serum nesfatin-1 and leptin levels in non-obese girls with premature thelarche.

Authors:  G Çatlı; A Anık; T Küme; Ö G Çalan; B N Dündar; E Böber; A Abacı
Journal:  J Endocrinol Invest       Date:  2015-04-02       Impact factor: 4.256

Review 6.  Peripheral signals mediate the beneficial effects of gastric surgery in obesity.

Authors:  Silvia Barja-Fernández; Cintia Folgueira; Cecilia Castelao; Rosaura Leis; Felipe F Casanueva; Luisa M Seoane
Journal:  Gastroenterol Res Pract       Date:  2015-04-15       Impact factor: 2.260

7.  Serum Nesfatin-1 Levels in Girls with Idiopathic Central Precocious Puberty.

Authors:  Ayça Altıncık; Oya Sayın
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-07-24

8.  Nesfatin-1 Regulates Feeding, Glucosensing and Lipid Metabolism in Rainbow Trout.

Authors:  Ayelén M Blanco; Cristina Velasco; Juan I Bertucci; José L Soengas; Suraj Unniappan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

Review 9.  Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.

Authors:  S Barja-Fernandez; R Leis; F F Casanueva; L M Seoane
Journal:  Drug Des Devel Ther       Date:  2014-12-01       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.